31. Brain+: Targeting the UK market, with Devika Wood, CEO of Brain+
Brain+ A/S is a leading innovator in digital therapeutics for dementia care. Through its flagship platform, Ayla, Brain+ delivers cognitive stimulation therapy (CST) and data-driven insights to improve patient outcomes. In this episode, Brain+’s newly appointed CEO Devika Wood, shares her background in digital health and her vision for the company’s potential. She explains how the Ayla platform delivers Cognitive Stimulation Therapy to improve memory and attention, and discusses the UK healthcare system and efforts to integrate Brain+’s CST solution. She also describes how the efficacy of their CST therapy is validated, and outlines Brain+’s licensing model in the UK dementia care market, sales pipeline targets, and roadmap for expansion.FinVoices is powered by Impala Nordic. The host for this episode is Vilhelm Ruhr, Analyst at Impala Nordic. Disclaimer** Nothing mentioned in the podcast constitutes a buy or sell recommendation. The episode was produced on behalf of the company. Impala Nordic and any individuals or entities associated with it do not hold shares in the company. Hosted on Acast. See acast.com/privacy for more information.